BIOCRYST PHARMACEUTICALS, INC. Debt Securities, Available-for-sale, Noncurrent
BIOCRYST PHARMACEUTICALS, INC. (BCRX) had Debt Securities, Available-for-sale, Noncurrent of $3.00 million as of 2020-09-30, per its 10-Q filed 2020-11-06.
Discontinued › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent · last filed 2020-11-06
- 2020-09-30: Debt Securities, Available-for-sale, Noncurrent $3.00M.
- 2019-12-31: Debt Securities, Available-for-sale, Noncurrent $0.00.
- 2019-06-30: Debt Securities, Available-for-sale, Noncurrent $741.00K.
- 2019-03-31: Debt Securities, Available-for-sale, Noncurrent $11.65M.
| Period end | Debt Securities, Available-for-sale, Noncurrent |
|---|---|
| 2020-09-30 | $3.00M 10-Q · filed 2020-11-06 |
| 2019-12-31 | $0.00 10-Q · filed 2020-11-06 |
| 2019-06-30 | $741.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $11.65M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $22.38M 10-K · filed 2020-03-13 |
| 2018-09-30 | $29.16M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $33.74M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $41.60M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $41.30M 10-K · filed 2019-03-14 |
| 2017-09-30 | $4.54M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $9.60M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $3.80M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $8.93M 10-K · filed 2018-03-12 |
| 2016-09-30 | $14.37M 10-Q · filed 2016-11-08 |
| 2016-06-30 | $24.15M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $41.13M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $47.68M 10-K · filed 2017-02-27 |
| 2015-09-30 | $47.79M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $36.06M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $41.12M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $41.12M 10-K · filed 2016-02-26 |
| 2014-09-30 | $302.00K 10-Q · filed 2014-11-07 |
| 2014-06-30 | $602.00K 10-Q · filed 2014-08-08 |
| 2014-03-31 | $2.68M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $2.58M 10-K · filed 2015-03-02 |
| 2013-09-30 | $680.00K 10-Q · filed 2013-11-08 |
| 2012-12-31 | $1.15M 10-K · filed 2014-03-10 |
| 2012-09-30 | $2.51M 10-Q · filed 2012-11-08 |
| 2012-06-30 | $16.35M 10-Q · filed 2012-08-08 |
| 2011-12-31 | $15.38M 10-K · filed 2013-03-11 |
| 2011-09-30 | $16.42M 10-Q · filed 2011-11-03 |
| 2011-06-30 | $12.98M 10-Q · filed 2011-08-04 |
| 2010-12-31 | $11.77M 10-Q · filed 2011-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |